Ilkka Ilonen, M.D., M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Zenker Diverticulum | 2 | 2023 | 28 | 1.640 |
Why?
|
Pleural Neoplasms | 9 | 2023 | 584 | 1.600 |
Why?
|
Hernia, Hiatal | 4 | 2023 | 91 | 1.350 |
Why?
|
Mesothelioma | 8 | 2023 | 774 | 1.320 |
Why?
|
Thoracic Surgery, Video-Assisted | 5 | 2021 | 297 | 1.230 |
Why?
|
Lung Neoplasms | 26 | 2025 | 13499 | 1.210 |
Why?
|
Thoracotomy | 3 | 2019 | 374 | 1.010 |
Why?
|
Pneumonectomy | 5 | 2021 | 1148 | 0.990 |
Why?
|
Thymectomy | 2 | 2023 | 200 | 0.990 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 13 | 2025 | 5394 | 0.920 |
Why?
|
Finland | 7 | 2022 | 609 | 0.830 |
Why?
|
Esophageal Neoplasms | 7 | 2023 | 1663 | 0.760 |
Why?
|
Esophagoscopy | 1 | 2023 | 398 | 0.750 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.740 |
Why?
|
Dialysis | 3 | 2008 | 72 | 0.640 |
Why?
|
Peritoneal Neoplasms | 3 | 2020 | 707 | 0.640 |
Why?
|
Malpractice | 1 | 2023 | 561 | 0.620 |
Why?
|
Thymus Gland | 1 | 2023 | 1266 | 0.610 |
Why?
|
Digestive System Surgical Procedures | 1 | 2023 | 585 | 0.610 |
Why?
|
Laparoscopy | 3 | 2023 | 2042 | 0.550 |
Why?
|
Liver Failure, Acute | 3 | 2008 | 182 | 0.550 |
Why?
|
Gambling | 1 | 2018 | 192 | 0.490 |
Why?
|
Adenocarcinoma | 6 | 2023 | 6371 | 0.460 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 1232 | 0.430 |
Why?
|
Esophagectomy | 5 | 2023 | 478 | 0.410 |
Why?
|
Thoracic Surgical Procedures | 1 | 2014 | 348 | 0.350 |
Why?
|
Albumins | 3 | 2008 | 577 | 0.330 |
Why?
|
Insurance, Health | 1 | 2021 | 2517 | 0.320 |
Why?
|
Health Care Costs | 1 | 2021 | 3239 | 0.300 |
Why?
|
Cachexia | 2 | 2019 | 202 | 0.280 |
Why?
|
Multiple Organ Failure | 2 | 2006 | 388 | 0.280 |
Why?
|
Immunosorbent Techniques | 1 | 2006 | 174 | 0.270 |
Why?
|
Glutathione | 1 | 2009 | 589 | 0.260 |
Why?
|
Retrospective Studies | 23 | 2024 | 81746 | 0.250 |
Why?
|
Peroxidase | 1 | 2009 | 610 | 0.250 |
Why?
|
Respiratory Tract Infections | 1 | 2013 | 1014 | 0.240 |
Why?
|
Quality of Life | 5 | 2020 | 13489 | 0.240 |
Why?
|
Survivors | 1 | 2014 | 2381 | 0.220 |
Why?
|
Asbestos | 2 | 2022 | 250 | 0.210 |
Why?
|
Aged | 27 | 2024 | 171446 | 0.200 |
Why?
|
Adenoviridae Infections | 1 | 2022 | 96 | 0.190 |
Why?
|
Neoplasm Staging | 9 | 2024 | 11221 | 0.190 |
Why?
|
Antineoplastic Agents | 3 | 2025 | 13658 | 0.190 |
Why?
|
Osteonectin | 1 | 2021 | 33 | 0.190 |
Why?
|
Dendritic Cells, Follicular | 1 | 2021 | 50 | 0.190 |
Why?
|
Cytokines | 5 | 2024 | 7450 | 0.180 |
Why?
|
Humans | 50 | 2025 | 767991 | 0.180 |
Why?
|
Survival Analysis | 6 | 2021 | 10098 | 0.180 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 183 | 0.170 |
Why?
|
Female | 35 | 2025 | 397113 | 0.170 |
Why?
|
Epithelioid Cells | 1 | 2020 | 60 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2023 | 65364 | 0.160 |
Why?
|
Learning Curve | 1 | 2021 | 232 | 0.160 |
Why?
|
Male | 31 | 2024 | 364641 | 0.160 |
Why?
|
Funnel Chest | 1 | 2020 | 75 | 0.160 |
Why?
|
Middle Aged | 26 | 2024 | 223422 | 0.160 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39345 | 0.150 |
Why?
|
Oncolytic Viruses | 1 | 2022 | 344 | 0.150 |
Why?
|
Platinum | 1 | 2019 | 222 | 0.150 |
Why?
|
Reoperation | 3 | 2023 | 4329 | 0.150 |
Why?
|
Thorax | 1 | 2021 | 557 | 0.150 |
Why?
|
Activins | 1 | 2019 | 211 | 0.150 |
Why?
|
Cohort Studies | 6 | 2023 | 41749 | 0.150 |
Why?
|
Thoracic Wall | 1 | 2020 | 203 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2009 | 3140 | 0.140 |
Why?
|
Myasthenia Gravis | 1 | 2020 | 214 | 0.140 |
Why?
|
Prognosis | 11 | 2024 | 29979 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2012 | 4050 | 0.140 |
Why?
|
Oncolytic Virotherapy | 1 | 2022 | 520 | 0.130 |
Why?
|
Interleukin-2 | 1 | 2023 | 1895 | 0.130 |
Why?
|
Disintegrins | 1 | 2016 | 27 | 0.130 |
Why?
|
Carcinoid Tumor | 1 | 2018 | 225 | 0.130 |
Why?
|
Deglutition Disorders | 1 | 2021 | 640 | 0.120 |
Why?
|
Liver Transplantation | 2 | 2006 | 2401 | 0.120 |
Why?
|
Mediastinal Neoplasms | 1 | 2018 | 403 | 0.120 |
Why?
|
Aged, 80 and over | 14 | 2024 | 59598 | 0.120 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1086 | 0.120 |
Why?
|
Depression | 1 | 2014 | 8231 | 0.120 |
Why?
|
Cell Line, Tumor | 4 | 2025 | 17128 | 0.120 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2908 | 0.120 |
Why?
|
ADAM Proteins | 1 | 2016 | 242 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2409 | 0.110 |
Why?
|
Adult | 18 | 2024 | 223583 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2061 | 0.110 |
Why?
|
Muscle, Skeletal | 2 | 2018 | 4978 | 0.100 |
Why?
|
Sarcopenia | 1 | 2018 | 378 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2016 | 495 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4351 | 0.100 |
Why?
|
Immunotherapy | 2 | 2024 | 4748 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2022 | 1807 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2025 | 3948 | 0.090 |
Why?
|
Peptide Library | 1 | 2012 | 351 | 0.090 |
Why?
|
Postoperative Complications | 5 | 2023 | 15831 | 0.090 |
Why?
|
Forecasting | 1 | 2020 | 2945 | 0.090 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2902 | 0.090 |
Why?
|
Necrosis | 2 | 2020 | 1616 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2025 | 5335 | 0.080 |
Why?
|
Registries | 3 | 2020 | 8377 | 0.080 |
Why?
|
Stents | 2 | 2018 | 3195 | 0.080 |
Why?
|
Adenoviridae | 2 | 2023 | 1092 | 0.080 |
Why?
|
Deoxyguanosine | 1 | 2009 | 96 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 836 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 1 | 2025 | 5694 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1193 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20757 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6843 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1695 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3237 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5366 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2020 | 22287 | 0.050 |
Why?
|
Respiration | 1 | 2010 | 1661 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 11873 | 0.050 |
Why?
|
Length of Stay | 3 | 2022 | 6495 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 146 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 40214 | 0.050 |
Why?
|
Interleukins | 1 | 2006 | 796 | 0.050 |
Why?
|
Validation Studies as Topic | 1 | 2021 | 162 | 0.050 |
Why?
|
Antioxidants | 1 | 2009 | 1674 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2010 | 2429 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2010 | 1107 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12828 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2012 | 5151 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2025 | 756 | 0.040 |
Why?
|
Gastrostomy | 1 | 2021 | 325 | 0.040 |
Why?
|
Liver Diseases | 1 | 2006 | 1305 | 0.040 |
Why?
|
Prospective Studies | 3 | 2019 | 54924 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 13000 | 0.040 |
Why?
|
Incidence | 3 | 2023 | 21532 | 0.040 |
Why?
|
Stomach | 1 | 2021 | 701 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8535 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2025 | 1996 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2016 | 6119 | 0.030 |
Why?
|
Young Adult | 3 | 2017 | 60048 | 0.030 |
Why?
|
Calcitonin | 1 | 2018 | 328 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1105 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 619 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2018 | 630 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 848 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2019 | 414 | 0.030 |
Why?
|
Mice | 4 | 2025 | 82024 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2276 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1904 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2019 | 1269 | 0.030 |
Why?
|
Serotonin | 1 | 2018 | 1043 | 0.030 |
Why?
|
Animals | 5 | 2025 | 169222 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1698 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36742 | 0.030 |
Why?
|
Liver | 1 | 2008 | 7574 | 0.020 |
Why?
|
Aorta | 1 | 2020 | 2045 | 0.020 |
Why?
|
Smoking | 1 | 2009 | 9089 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3628 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4354 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3437 | 0.020 |
Why?
|
Endoscopy | 1 | 2021 | 1854 | 0.020 |
Why?
|
Adolescent | 3 | 2009 | 89155 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4176 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1970 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 24314 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4576 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2025 | 8637 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5024 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2299 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26375 | 0.020 |
Why?
|
Hemorrhage | 1 | 2020 | 3467 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8507 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3488 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11068 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6517 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2665 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4258 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3620 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9016 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 74936 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10094 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15867 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12797 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10470 | 0.010 |
Why?
|
Mutation | 1 | 2025 | 30211 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9521 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13665 | 0.010 |
Why?
|